TY - JOUR
T1 - Robotic Hysterectomy in Severely Obese Patients With Endometrial Cancer
T2 - A Multicenter Study
AU - Corrado, Giacomo
AU - Chiantera, Vito
AU - Fanfani, Francesco
AU - Cutillo, Giuseppe
AU - Lucidi, Alessandro
AU - Mancini, Emanuela
AU - Pedone Anchora, Luigi
AU - Scambia, Giovanni
AU - Vizza, Enrico
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Study Objective: The aim of this study was to evaluate the surgical and oncologic outcomes of robotic hysterectomy with or without or less pelvic and aortic lymphadenectomy in severely obese patients (body mass index [BMI] ≥ 40 kg/m2) with endometrial cancer. Material and Methods: Between August 2010 and November 2014, patients with histologically confirmed endometrial cancer and BMI ≥40 kg/m2 were deemed eligible for the study and underwent RH with or without pelvic and aortic lymphadenectomy. Results: Seventy patients were divided into 3 groups according to their BMI: group A, BMI between 40 and 45 kg/m2 (50 patients); group B, BMI between 45 and 50 kg/m2 (10 patients); and group C, BMI above 50 kg/m2 (10 patients). No significant statistical differences were found between the 3 groups in terms of operation time, blood loss, hospital stay, and oncologic results. Pelvic lymphadenectomy was performed in 42%, 30%, and 20% of patients in groups A, B, and C, respectively. An intraoperative complication occurred in 1 patient in group A, early postoperative complications in 4 patients in group A and in 1 patient in group C, and a late postoperative complication occurred in 1 patient in group A. No conversions to laparotomy were necessary; however, 3 patients underwent conversions to laparoscopy in group A and 1 patient in both groups B and C. Conclusion: Our study showed that robotic surgery in severely obese patients with endometrial cancer is safe and feasible. Moreover, it seems that an increase in BMI does not change the surgical and oncologic outcomes. However, randomized controlled trials are needed to confirm these results.
AB - Study Objective: The aim of this study was to evaluate the surgical and oncologic outcomes of robotic hysterectomy with or without or less pelvic and aortic lymphadenectomy in severely obese patients (body mass index [BMI] ≥ 40 kg/m2) with endometrial cancer. Material and Methods: Between August 2010 and November 2014, patients with histologically confirmed endometrial cancer and BMI ≥40 kg/m2 were deemed eligible for the study and underwent RH with or without pelvic and aortic lymphadenectomy. Results: Seventy patients were divided into 3 groups according to their BMI: group A, BMI between 40 and 45 kg/m2 (50 patients); group B, BMI between 45 and 50 kg/m2 (10 patients); and group C, BMI above 50 kg/m2 (10 patients). No significant statistical differences were found between the 3 groups in terms of operation time, blood loss, hospital stay, and oncologic results. Pelvic lymphadenectomy was performed in 42%, 30%, and 20% of patients in groups A, B, and C, respectively. An intraoperative complication occurred in 1 patient in group A, early postoperative complications in 4 patients in group A and in 1 patient in group C, and a late postoperative complication occurred in 1 patient in group A. No conversions to laparotomy were necessary; however, 3 patients underwent conversions to laparoscopy in group A and 1 patient in both groups B and C. Conclusion: Our study showed that robotic surgery in severely obese patients with endometrial cancer is safe and feasible. Moreover, it seems that an increase in BMI does not change the surgical and oncologic outcomes. However, randomized controlled trials are needed to confirm these results.
KW - Endometrial cancer
KW - Morbidity obese
KW - Robotic hysterectomy
UR - http://www.scopus.com/inward/record.url?scp=84952631571&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952631571&partnerID=8YFLogxK
U2 - 10.1016/j.jmig.2015.08.887
DO - 10.1016/j.jmig.2015.08.887
M3 - Article
VL - 23
SP - 94
EP - 100
JO - Journal of Minimally Invasive Gynecology
JF - Journal of Minimally Invasive Gynecology
SN - 1553-4650
IS - 1
ER -